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Background: Of the 1.8 million global incident lung cancer cases estimated in 2012,
approximately 60% occurred in less developed regions. Prior studies suggest sex
differences in lung cancer risk and a potential role for reproductive and hormonal
factors in lung cancer among women. However, the majority of these studies were
conducted in developed regions. No prior study has assessed these relationships among
Nepali women.
Methods: Using data from a hospital-based case-control study conducted in
B. P. Koirala Memorial Cancer Hospital (Nepal, 2009–2012), relationships between
reproductive and hormonal factors and lung cancer were examined among women aged
23–85 years. Lung cancer cases (n= 268) were frequency-matched to controls (n= 226)
based on age (±5 years), ethnicity and residential area. The main exposures in this
analysis included menopausal status, age at menarche, age at menopause, menstrual
duration, gravidity, and age at first live-birth. Odds ratios (ORs) and 95% confidence
intervals (CIs) were estimated using multivariable logistic regression.
Results: Among postmenopausal women, those with a younger age at menopause
(<45 years; 45–49 years) had an increased odds of lung cancer compared to those
with an older (≥50 years) age at menopause [OR (95%CI): 2.14 (1.09, 4.17); OR (95%
CI): 1.93 (1.07, 3.51)], after adjusting for age and cumulative active smoking years.
No statistically significant associations were observed with the other reproductive and
hormonal factors examined.
Conclusion: These results suggest that Nepali women with prolonged exposure to
endogenous ovarian hormones, via later age at menopause, may have a lower odds of
lung cancer.
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INTRODUCTION
Lung cancer is the most commonly diagnosed cancer and the
primary cause of cancer mortality worldwide (1–4). Moreover,
approximately 60% of the global lung cancer incidence and
mortality occurs in less developed regions (LDRs) (3), which
include countries such as Nepal. Although lung cancer is one
of the three most common cancers among Nepali women (5),
epidemiologic data on the risk factors of lung cancer in LDRs
remains scarce (6, 7).
While smoking is a well-established risk factor for lung
cancer, several studies have suggested that reproductive and
hormonal factorsmay also play a role in lung cancer development
due to observed sex differences (8–12). These sex differences
include increased susceptibility to the carcinogenic effects of
tobacco (8–10) and a higher proportion of non-smoking lung
cancer diagnosed (11) among women, as compared to men.
Additionally, the distribution of histological subtypes differ by
sex with adenocarcinoma being more common among women
vs. squamous cell carcinoma in men (13). The presence of female
sex-hormone receptors (estrogen-β and progesterone) on lung
cancer cells (14) along with the patterns noted above support
hypotheses related to reproductive and hormonal factors and
lung cancer.
Prior epidemiological studies which investigated the
relationship between age at menarche (15–27), age at first birth
(15, 16, 18–25, 27, 28), and oral contraceptive use (17, 19–
22, 24, 27, 29) in relation to lung cancer risk have reported no
statistically significant associations, while only one study to
date has examined the relationship between gravidity and lung
cancer and observed no statistically significant association (16).
More recent cohort studies conducted in the United States have
observed an inverse association between lung cancer risk and age
at menopause (20–23), and longer reproductive periods (22, 24)
lending support to these potential associations. Despite these
limited prior studies, reproductive and hormonal factors have
not been examined in relation to lung cancer among Nepali
women, an understudied population with differential patterns of
these exposures.
Given the increased lung cancer global burden in LDRs (1, 2)
such as Nepal, the suggested higher susceptibility among women
(8–12), and the above-mentioned biological rationale, relations
between reproductive and hormonal factors and lung cancer
among Nepali women were examined. We hypothesized that
the odds of lung cancer among Nepali women may differ by
factors such as age at menarche, age at menopause, menstrual




This study utilizes data from a hospital-based case-control study,
conducted between November 2009 and December 2012, at the
B. P. Koirala Memorial Cancer Hospital (BPKMCH) in the city
of Bharatpur, Chitwan district (30, 31). The primary study is
described in previous publications (30, 31).
Briefly, 606 lung cancer cases and 606 frequency-matched
controls, based on age (±5 years), sex, ethnicity, and residential
area (district), were recruited, including 268 female lung cancer
cases and 226 female frequency-matched hospital-based controls.
One lung cancer case was excluded due to a previous breast
cancer diagnosis. Thus, the final analytic population for this study
included 493 women (267 cases and 226 controls).
Lung cancer was defined according the International
Classification of Diseases for Oncology, 2nd Edition (ICD-O2)
codes C33 (trachea) and C34 (bronchus and lung). Eligible
cases included patients diagnosed with primary lung cancer at
the BPKMCH. Eligible controls included visitors (family and
friends) of non-lung cancer patients, subjects being screened for
cancer and subjects accompanying the person being screened,
at the BPKMCH during the study period. Although the primary
study aimed to frequency-match cases and controls based on sex,
hospital visitors were less likely to be women, and thus, fewer
female controls were recruited. Lung cancer patients younger
than 18 years of age and not residing in Nepal for at least 5 years
were excluded.
All eligible participants were interviewed in-person
by a trained nurse, who collected detailed information
including tobacco and alcohol consumption, reproductive
and hormonal factors, medical conditions, family history of
cancer, anthropometrics and other factors using a standardized
questionnaire. A target interval of 1 day and a maximal interval
of 3 months between diagnosis and recruitment were used for
data attainment in order to minimize selection bias. Informed
written consent was obtained from the study participants prior to
enrollment. Institutional Review Board approvals were obtained
from the University of Utah, University of Maryland and the
Nepal Health Research Council.
Exposure Assessment
Reproductive and hormonal exposures assessed include
menstrual duration (continuous in years), menopausal status
(premenopausal, postmenopausal), age at menarche (<14,
14, ≥15 years), age at menopause (<45, 45–49, ≥50 years),
number of pregnancies (≤2, 3–5,>5), age at first live-birth (<18,
18–20, ≥21 years) and birth control use (ever/never). Among
postmenopausal women, menstrual duration was defined as the
difference between the participants’ reported age at menarche
and age at menopause. Menopausal status was defined based on
whether women reported still menstruating (premenopausal)
or had stopped menstruating (postmenopausal) at the time
of questionnaire completion. Menopausal status and age at
menopause were combined into one variable for analyses
(premenopausal, <45, 45–49,≥50 years).
Covariate Assessment
Detailed information was collected on the type, duration and
quantity of tobacco product smoked, including cigarettes with or
without filter, bidi, choor or kankat, hooka or pipe, and hashish.
Cumulative active smoking (CAS; continuous) was defined as the
sum of the total years of use of the above tobacco products. Pack-
years of smoking (continuous) was calculated by multiplying
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years of use by frequency of use (per day) divided by 20 for each
tobacco product.
Statistical Analysis
Descriptive characteristics of the cases and controls were
compared using t-tests and Chi-square tests. Odds ratios
(ORs) and 95% confidence intervals (CIs) for associations
between exposures noted above and lung cancer (outcome)
were estimated using multivariable logistic regression.
Continuous variable measurements were categorized based
on distributions among the controls; missing values were
categorized as “unknown.”
Based on prior literature, potential confounders were
identified a priori, including age, smoking history, body mass
index (BMI, kg/m2), residential history, ethnicity, marital status,
education, family monthly income, first degree family history
of cancer, history of medical condition (including tuberculosis,
asthma and pneumonia), and alcohol consumption. As smoking
is a well-established lung cancer risk factor, CAS was included
in all models and the above-mentioned potential confounders
were subsequently added to determine if estimated ORs changed
by more than 10%. After adjusting for CAS, none of the
above-mentioned potential confounders changed the estimated
ORs by more than 10%. Thus, the final parsimonious models
included adjustment for age and CAS, and are presented herein.
Additionally, a final model that simultaneously adjusted for
all reproductive and hormonal exposure variables of interest,
in addition to adjustment for age and CAS, was performed
using logistic regression. Model diagnostics were performed for
the final models. One subject with missing cumulative active
smoking history was excluded from all analyses.
Given the strong relationship between smoking and lung
cancer, we also examined associations stratified by cumulative
active smoking years. CAS categories (<15 years and≥ 15 years),
for the stratified analysis, were based on the mean cumulative
active smoking years among the controls.
Tests for trend were performed by modeling each categorical
exposure as an ordinal variable using logistic regression. The SAS
statistical package, version 9.3, was used for all statistical analyses.
All p-values were 2-sided.
RESULTS
Descriptive characteristics of the study population are presented
by case status (N = 267 cases, 226 controls) in Table 1A.
Compared to controls, cases were slightly older (mean age
(years) ± standard deviation (SD): 59.2 ± 11.6 vs. 53.2 ± 9.6,
p < 0.0001), less educated (3.8% of cases completed high school
vs. 12% of controls, p < 0.0001), and had lower family income
(25.8% with a monthly family income ≤ 999 rupees compared
to 12.8% of controls, p = 0.0002). Additionally, cases were more
likely to be unmarried or widowed (30 vs. 15.5% of controls,
p = 0.0002) and to reside in rural areas (86.9% compared to
79.2% of controls, p = 0.02). Cases and controls also varied in
their ethnic background (p < 0.0001); controls had a higher
proportion of Brahmins (29.2%) compared to cases (11.6%), and
more than fifty percent of cases were included in the “other”
ethnic groups.
In terms of lifestyle factors, cases were significantly more
likely to use tobacco products (p < 0.0001), consume alcohol
(p < 0.0001), and to have a slightly lower BMI (p < 0.0001).
When smoking behaviors were analyzed in more detail, results
indicated that cases reported greater cumulative active smoking
years (mean ± SD: 49.6 ± 32.5 vs. 15.1 ± 23.2, p < 0.0001)
and pack-years of smoking (mean ± SD: 24.7 ± 28.2 versus 5.5
± 11.9, p < 0.0001). The difference between cases and controls
was not statistically significant for years of filtered cigarette
use (p = 0.1). Nevertheless, these groups were significantly
different with respect to years of use of unfiltered cigarettes
(p < 0.0001), bidi (p < 0.0001), choor or kankat (p < 0.0001),
and hooka or hashish (p = 0.02). Cases were also more likely to
report a prior history of tuberculosis (p = 0.01) and pneumonia
diagnosis (p= 0.04).
Distributions of reproductive and hormonal characteristics
were examined among cases and controls (Table 1B), with a
similar mean age at menarche (p = 0.17), and age at first live-
birth (p= 0.9) observed between both groups. However, a greater
proportion of controls reported they were still menstruating
(p < 0.0001), using birth control (p = 0.04), and on average, had
fewer pregnancies (p= 0.005).
Among postmenopausal women, those with a younger age
at menopause (<45 years and 45–49 years) had an increased
odds of lung cancer compared to women who were ≥50 years at
menopause [OR (95% CI): 2.14 (1.09, 4.17) and 1.93 (1.07, 3.51),
respectively], after adjusting for age and CAS years (Table 2). The
linear trend for age at menopause, with respect to lung cancer,
was also statistically significant (p-trend: 0.02) suggesting a dose-
response relationship. Furthermore, among postmenopausal
women, women with a longer menstrual duration had a slightly
decreased odds of lung cancer compared to those with a shorter
menstrual duration [age and CAS adjusted OR (95% CI): 0.93
(0.88, 0.98)]. Lastly, women who were still menstruating had
a decreased odds of lung cancer compared to those who had
stopped menstruating [OR (95% CI): 0.41 (0.20, 0.85)]. All other
reproductive and hormonal factors examined were not associated
with lung cancer, after adjusting for age and CAS.
While the magnitude of the odds of lung cancer among
postmenopausal women with a younger age at menopause (<45
years and 45–49 years) remained elevated [OR (95% CI): 1.7
(0.90, 3.4) and OR (95% CI): 1.7 (0.90, 3.2), respectively],
the estimates were no longer statistically significant after
simultaneous adjustment for all reproductive and hormonal
factors (Table 3). No other significant relationships with lung
cancer were observed at α = 0.05.
After stratifying by cumulative active smoking (CAS) years
(Table 4), younger age at menopause (specifically <45 years)
remained significantly associated with a higher odds of lung
cancer among postmenopausal women with a cumulative active
smoking history of at least 15 years [OR (95% CI): 2.27 (1.02,
5.04)]. Similarly, among postmenopausal women, the inverse
relationship between menstrual duration and lung cancer only
remained significant among those who reported smoking for≥15
cumulative years over their lifetime. Women who reported to be
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TABLE 1A | Characteristics of women enrolled in the hospital-based lung cancer case-control study in Bharatpur, Nepal, 2009–2012 (n = 493).
Cases (n = 267) Controls (n = 226) p-valuea
Mean ± SD
Age (years) 59.2 ± 11.6 53.2 ± 9.6 <0.0001
BMI (kg/m2) 20.1 ± 3.5 22.6 ± 4.0 <0.0001
Years of tobacco product use
Cigarettes with filter 5.5 ± 12.5 3.8 ± 10.2 0.1
Cigarettes without filter 24.9 ± 22.5 7.0 ± 13.6 <0.0001
Bidi 12.3 ± 19.5 2.7 ± 8.9 <0.0001
Choor/kankat 4.6 ± 13.0 0.9 ± 5.3 <0.0001
Hooka/pipe & hashish 2.2 ± 10.8 0.5 ± 3.9 0.02
Cumulative number of active smoking years 49.6 ± 32.5 15.1 ± 23.2 <0.0001
Pack-years of smoking 24.7 ± 28.2 5.5 ± 11.9 <0.0001
N %b N %b p-valuec
Ethnicity <0.0001
Brahmin 31 11.6 66 29.2
Chettri 56 21 37 16.4
Madishe/tharu 29 10.9 22 9.7
Other 151 56.6 101 44.7
Marital status 0.0002
Married 187 70.0 191 84.5
Unmarried/widowed 80 30.0 35 15.5
Residential area 0.02
Urban 35 13.1 47 20.8
Rural 232 86.9 179 79.2
Education <0.0001
None 242 90.6 157 69.5
Elementary 15 5.6 42 18.6
High school 10 3.8 27 12.0
Family monthly income (rupees) 0.0002
≤ 999 69 25.8 29 12.8
1000–1999 74 27.7 55 24.3
≥ 2000 124 46.4 142 62.8
First degree family history of cancer (yes) 79 29.6 57 25.2 0.28
History of tuberculosis (yes) 30 11.2 11 4.9 0.01
History of asthma (yes) 23 8.6 14 6.2 0.3
History of pneumonia (yes)d 13 4.9 3 1.3 0.04
Alcohol consumption (ever) 94 35.2 42 18.6 <0.0001
Tobacco use (ever) 234 87.6 97 42.9 <0.0001
BMI, body mass index; SD, standard deviation; N, number of participants.
aP-values generated by t-test.
bPercentages may not add up to 100 because of rounding.
cP-values generated by chi-square test.
dThere was one missing value, which was not included in the test.
still menstruating had decreased odds of lung cancer within both
strata (<15 and≥15 years) of CAS. Lastly, other factors examined
(i.e., age at menarche, number of pregnancies, age at first birth,
age at first live-birth and birth control use) were not associated
with lung cancer within both strata of cumulative active smoking,
similar to the overall analysis.
DISCUSSION
Findings from this first analysis of reproductive and hormonal
factors in relation to lung cancer among Nepali women suggest
a potential role of menstrual factors in lung cancer. Specifically,
later age atmenopause was significantly associated with a reduced
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TABLE 1B | Reproductive and hormonal characteristics of women by case status.
Cases (n = 267) Controls (n = 226) p-valuea
Mean ± SD
Menstrual durationb (years) 31.2 ± 5.2 32.2 ± 5.1 0.09
Age at menopauseb (years) 46.3 ± 5.0 46.9 ± 4.8 0.3
Age at menarche (years) 14.9 ± 1.7 14.7 ± 1.6 0.3
Number of pregnancies (gravidity) 5.1 ± 2.6 4.4 ± 2.4 0.003
Age at first birthc (years) 20.0 ± 3.5 19.8 ± 3.3 0.42
Age at first live birthc (years) 20.1 ± 3.6 19.8 ± 3.4 0.38
N %d N %d p-valuea
Still menstruating (yes) 25 9.4 71 31.4 <0.0001
Age at menarche (years) 0.17
<14 46 17.2 50 22.1
14 58 21.7 62 27.4
≥15 134 50.2 101 44.7
Age at menopause (years) <0.0001
Premenopausal 25 9.4 71 31.4
<45 61 22.9 39 17.3
45–49 98 36.7 55 24.3
≥50 71 26.6 52 23.0
Number of pregnancies (gravidity) 0.005
≤2 40 15.0 43 19.0
3–5 116 43.5 121 53.5
>5 111 41.6 62 27.4
Age at first birth (years) 0.8
Never Pregnant 15 5.6 10 4.4
<18 50 18.7 47 20.8
18–20 100 37.5 80 35.4
≥21 77 28.8 69 30.5
Age at first live-birth (years) 0.9
Never Pregnant 15 5.6 10 4.4
<18 50 18.7 47 20.8
18–20 98 36.7 80 35.4
≥21 79 29.6 69 30.5
Birth control use (ever) 29 10.9 39 17.3 0.04
SD, standard deviation; N, number of participants.
aP-values generated by t-test or chi-square test; unknown category or missings excluded.
bOnly among postmenopausal women.
cOnly among women who reported being pregnant.
dPercentages may not add up to 100 because of rounding and due to unknown categories (not shown).
odds of lung cancer, after adjusting for age and cumulative
active smoking. These findings add to the growing body of
literature that point to a complex pattern of association between
reproductive hormones and lung cancer and contribute new
information regarding these exposures among Nepali women, an
understudied population.
Our findings with regard to age at menopause is consistent
with the few large prospective cohort studies conducted among
mainly Caucasian populations in the United States (US) (20,
21, 23), Canada (16) and Italy (22) that observed an inverse
association between lung cancer and later age at menopause.
However, mixed results have been observed among studies
conducted among Chinese populations. More specifically, two
cohort studies among non-smoking women (24, 26) and a case-
control study (15), found an inverse association, whereas, a
cohort study among female textile workers in Shanghai (25)
found no association between age at menopause and lung cancer
risk. Different smoking patterns and other life-style factors may
play a role in the inconsistent results observed among these
populations. Nepali women have been reported to have an
average age at menopause between 46.8 and 49.9 years (32–36),
which is similar to the average age at menopause observed in
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TABLE 2 | Multivariable odds ratios and 95% confidence intervals for the
relationship between reproductive and hormonal factors and lung cancer in the
hospital-based lung cancer case-control study, 2009–2012.
Cases Controls Age & CAS adjusteda
N N OR (95% CI)
Menstrual durationb (years) 213 142 0.93 (0.88, 0.98)
Still menstruating
Yes 25 71 0.41 (0.20, 0.85)
No 196 114 1 (referent)
Age at menarche (years)
<14 46 50 0.93 (0.53, 1.62)
14 58 62 0.88 (0.52,1.49)
≥15 134 101 1 (referent)
p-trenda 0.77
Age at menopauseb (years)
<45 61 39 2.14 (1.09, 4.17)
45–49 98 55 1.93 (1.07, 3.51)
≥50 71 52 1 (referent)
p-trenda 0.02
Number of pregnancies (gravidity)
≤2 40 43 0.87 (0.48, 1.57)
3–5 116 121 1 (referent)
>5 111 62 1.27 (0.78, 2.08)
p-trenda 0.21
Age at first live-birth (years)
Never pregnant 15 10 1.07 (0.38, 3.00)
<18 50 47 0.80 (0.44, 1.44)
18–20 98 80 1 (referent)
≥21 79 69 0.76 (0.45, 1.28)
p-trenda 0.76
Birth control use
Ever 29 39 0.79 (0.42, 1.50)
Never 227 177 1 (referent)
CAS, Cumulative Active Smoking; N, number of participants; OR, odds ratio; CI,
confidence interval.
aEstimates were adjusted for age and cumulative active smoking years; one subject with
missing cumulative active smoking history was excluded.
bPremenopausal women not included.
Unknown categories were retained in all models but not presented here.
the present analysis (cases: 46.3 vs. controls: 46.9 years). The
median age at menopause among white women in industrialized
countries is reported to be between 50 and 52 years (37).
Additional studies may be helpful in clarifying the relationships
between these factors and lung cancer among the Nepali women
population, with its unique distribution of sociodemographic,
lifestyle, smoking and health-related behaviors.
Menstrual duration reflects a woman’s reproductive period
during which she is exposed to hormones produced and secreted
by her ovaries, such as estrogen (38). We observed an inverse
association between menstrual duration and lung cancer which
is in-line with findings from previous studies that have also
examined this relationship (22, 24). More specifically, a cohort
study among lifetime non-smokers in China (24) and a case-
control study among Italian women (22) also observed a reduced
TABLE 3 | Mutually adjusted odds ratios and 95% confidence intervals of
reproductive and hormonal factors in relation to lung cancer in the hospital-based
lung cancer case-control study.
Cases Controls Mutually adjusteda
N N OR (95% CI)
Age at menarche (years)
<14 46 50 1.04 (0.57, 1.87)
14 58 62 0.84 (0.48, 1.46)
≥15 134 101 1 (referent)
Age at menopause (years)
Premenopausal 25 71 0.71 (0.29, 1.70)
<45 61 39 1.74 (0.90, 3.38)
45–49 98 55 1.72 (0.94, 3.15)
≥50 71 52 1 (referent)
Number of pregnancies (gravidity)
≤2 40 43 0.82 (0.40, 1.68)
3–5 116 121 1 (referent)
>5 111 62 1.15 (0.69, 1.91)
Age at first live-birth (years)
Never Pregnant 15 10 2.39 (0.55, 10.36)
<18 50 47 0.75 (0.40, 1.41)
18–20 98 80 1 (referent)
≥21 79 69 0.77 (0.45, 1.31)
Birth control use
Ever 29 39 0.82 (0.42, 1.59)
Never 227 177 1 (referent)
OR, odds ratio; CI, confidence interval.
aEstimates were simultaneously adjusted for all reproductive and hormonal exposures
listed above, in addition to adjustment for age and cumulative active smoking years; one
subject with missing cumulative active smoking history was excluded.
Unknown categories were retained in the model but not presented here.
risk of lung cancer among women with a longer reproductive
period. Potential mechanisms for this association are unclear,
however, reproductive hormones, estrogen and progesterone,
are suggested in the development of lung cancer, in part, due
to sex differences in the observed incidence of lung cancer by
subtype (13, 39). Additionally, evidence supports the presence
of receptors for Estrogen-β and progesterone in lung cancer
cells (14, 40). Prior studies have also reported that women may
be more susceptible to the carcinogenic effects of tobacco (8–
10), suggesting hormones may play a role. However, the specific
mechanisms whereby duration of endogenous estrogen exposure,
as measured by duration of menstruation and age at menopause
in our study, influences lung cancer requires further mechanistic
studies. Complex combinations of hormonal and environmental
exposures, such as tobacco consumption, are likely to impact
development of distinct histological subtypes of lung cancer.
Interestingly, a case-control analysis conducted by Koushik
et al. among 422 women with lung cancer and 577 controls
in Canada found an increased risk of lung cancer among
women who had a non-natural menopause (predominantly
including women who had a bilateral oophorectomy) compared
to women who had a natural menopause (16). Koushik et al.
also observed an inverse association between age at menopause
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TABLE 4 | Multivariable odds ratios and 95% confidence intervals of the relationship between reproductive and hormonal and lung cancer by smoking status.
<15 Cumulative active smoking years ≥15 Cumulative active smoking years
Cases Controls OR (95% CI)a Cases Controls OR (95% CI)a
n n n n
Menstrual durationb (years) 18 81 0.95 (0.84, 1.07) 194 61 0.92 (0.87, 0.98)
Still menstruating
Yes 17 60 0.30 (0.10, 0.92) 8 11 0.29 (0.09, 0.88)
No 17 61 1 (referent) 179 53 1 (referent)
Age at menarche (years)
<14 11 32 1.68 (0.65, 4.30) 35 18 0.71 (0.35, 1.44)
14 10 45 1.01 (0.39, 2.61) 48 17 0.89 (0.44, 1.78)
≥15 13 64 1 (referent) 120 37 1 (referent)
p-trenda 0.32 0.37
Age at menopauseb (years)
<45 6 25 2.46 (0.49, 12.24) 55 14 2.27 (1.02, 5.04)
45–49 10 33 3.33 (0.76, 14.60) 88 22 1.81 (0.92, 3.57)
≥50 3 25 1 (referent) 67 27 1 (referent)
p-trenda 0.45 0.03
Number of pregnancies (gravidity)
≤2 9 27 1.20 (0.46, 3.13) 31 16 0.62 (0.29, 1.32)
3–5 19 85 1 (referent) 96 36 1 (referent)
>5 10 34 1.88 (0.72, 4.92) 101 28 1.10 (0.60, 2.00)
p-trenda 0.48 0.19
Age at first live-birth (years)
Never pregnant 4 5 3.78 (0.81, 17.62) 11 5 0.45 (0.13, 1.51)
<18 9 27 1.90 (0.67, 5.37) 41 20 0.52(0.25, 1.10)
18–20 11 58 1 (referent) 87 22 1 (referent)
≥21 9 42 1.06 (0.39, 2.88) 70 27 0.58 (0.30, 1.14)
p-trenda 0.35 0.99
Birth control use
Ever 9 28 1.07 (0.43, 2.65) 19 11 0.63 (0.26, 1.49)
Never 27 115 1 (referent) 200 62 1 (referent)
OR, odds ratio; CI, confidence interval.
aEstimates were adjusted for age and cumulative active smoking years, and exposures listed in the above table as applicable; one subject with missing cumulative active smoking history
was excluded.
bPremenopausal women not included.
and lung cancer risk (16). We were unable to conduct stratified
analysis by type of menopause or lung cancer subtypes, or
conduct a restricted analysis among non-smoking women only,
which could provide further insights to our finding among the
Nepali population.
Prior studies that examined age at menarche and lung cancer
risk have been inconsistent.We found a null relationship between
age at menarche and lung cancer which is consistent with
various case-control (16–19) and prospective cohort studies (20,
24–27) conducted among Chinese (18, 24–26), Canadian (16,
27), American (19, 20), and German (17) women populations.
However, other studies have also reported an inverse association
between age at menarche and lung cancer among Chinese (15)
and American (21) women. Based on prior studies, the mean
age at menarche among Nepali girls ranges from 12 to 14.8
years of age (41–43). However, despite the older age at menarche
among Nepali women in our study (mean ± SD: 14.7 ± 1.6)
vs. US women (20) (mean ± SD: 12.5 ± 1.4), we also observed
a null association. Our observations among Nepali women add
important and much needed information to the existing body of
literature in this area.
With regard to gravidity, age at first birth, and birth control
use in relation to lung cancer, our null findings are also
consistent with the majority of the epidemiologic studies that
have examined these associations. Only one prior study has
examined the relationship between gravidity and lung cancer
(16). Similar to our findings, this population-based case-control
study observed no statistically significant association between
gravidity and lung cancer (16). Results from the current analysis
of age at live-birth and age at first birth are similar to several
studies that observed a null relationship between age at first
birth and lung cancer (15, 16, 18–20, 22, 24, 25, 28). Conversely,
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Brinton et al. (21) and Kabat et al. (27) reported an inverse
association between age at first birth and lung cancer in the NIH-
AARP Diet and Health Study and the Canadian National Breast
Screening Study cohorts. Differences in the study design as well
as the prevalence of exposures may, in part, explain disparate
results. The median age at first birth among Nepali women aged
25–49 years was reported to be 20.2 years based on national data
(44), which is similar to the mean age at first birth within our
study population (cases: 20.0 ± 3.5 years vs. controls: 19.8 ± 3.3
years). Based on the National Vital Statistics Reports (NVSR), the
mean age at first birth for women in the US was 26.8 years in 2017
(45). As no prior study has examined the relationship between age
at first birth and lung cancer among Nepali women, our results
contribute to the understanding of reproductive risk factors in
this unique population with a different exposure pattern. Lastly,
the null association observed between birth control use and lung
cancer risk in the current study, is consistent with the majority
of prior studies (19–22, 24, 27, 29). Although the patterns of
gravidity, age at first birth and birth control use among ourNepali
population differ from those in the predominantly Caucasian or
Chinese populations of the previous studies, the consistency of
findings reported across multiple populations lend support to
these associations.
The majority of Nepali women, particularly the lung cancer
cases, in our analytic population reported smoking (only 12.4%
of the cases and 57.1% of the controls never smoked), limiting
our ability to assess relationships between reproductive and
hormonal exposures and lung cancer among non-smokers.
Although we stratified our analysis by cumulative active smoking
(<15, ≥15 years), few cases within our analytic population
reported smoking <15 CAS years. A recent cross-sectional
study among Nepali women 15–49 years of age reported the
prevalence of tobacco consumption to be 43.6% (46). However,
in the United States (and countries similar), the prevalence of
smoking is much lower; 13.5% as reported by the Centers for
Disease Control and Prevention (47). Given the long-standing
relationship between tobacco smoking and lung cancer, it is not
surprising that in our population, lung cancer cases smoked
tobacco significantly longer compared to controls (mean (year):
49.6 vs. 15.1; p < 0.0001). Furthermore, our data reflect the
high prevalence of smoking in this population. Nonetheless,
due to the limited sample size within the CAS strata, findings
from the smoking stratified analyses should be interpreted with
caution and corroborated in a larger sample of non-smoking
Nepali women. Additionally, the prevalence of EGFR mutations,
ALK rearrangement and ROS1 within our study population
is unknown as we have not measured these genetic markers.
Associations also could not be analyzed by strata of menopausal
status, due to the limited number of premenopausal women in
our study population. Data on the type of menopause (natural,
surgical, or other) was also not available. This information may
help in elucidating relationships between age at menopause
and lung cancer. Finally, information on lung cancer histology
and specific types of birth control use may have provided
additional clarification.
Despite these limitations, this is one of the few epidemiological
studies examining potential lung cancer risk factors in Nepal
(30, 31, 48–50), a country with limited cancer research resources
and is the first study to examine the relationship between
reproductive and hormonal factors and lung cancer among
Nepali women. Additionally, studies that have examined the
prevalence of reproductive and hormonal factors among Nepali
women are scarce, and this study contributes much needed
prevalence data on these exposures among Nepali women. The
use of trained nurses via in-person interviews, standardized
questionnaires, and detailed information on type, duration and
quantity of tobacco products used are strengths of this study. In
addition to contributing to the epidemiological body of evidence
surrounding potential associations between reproductive and
hormonal factors and lung cancer, this study contributes much
needed information on the distribution of these risk factors
among Nepali women.
Lung cancer is one of the three most common cancers
diagnosed among Nepali women, and thus, it is crucial to
understand and characterize the prevalence of risk factors in
this population. However, research within the Nepali women
population is lacking. Findings from this analysis contribute
to our understanding of lung cancer occurring among Nepali
women with a different prevalence of reproductive and hormonal
factors and a high rate of lung cancer incidence. Further
research is need to disentangle the relationship between smoking,
reproductive and hormonal factors and lung cancer within
this population and to assess the clinical applications of
these associations.
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